Becker, T.; Heitkötter, J.; Krome, A.K.; Schiefer, A.; Pfarr, K.; Ehrens, A.; Grosse, M.; Sandargo, B.; Stammberger, I.; Stadler, M.;
et al. Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations. Pharmaceutics 2024, 16, 386.
https://doi.org/10.3390/pharmaceutics16030386
AMA Style
Becker T, Heitkötter J, Krome AK, Schiefer A, Pfarr K, Ehrens A, Grosse M, Sandargo B, Stammberger I, Stadler M,
et al. Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations. Pharmaceutics. 2024; 16(3):386.
https://doi.org/10.3390/pharmaceutics16030386
Chicago/Turabian Style
Becker, Tim, Jan Heitkötter, Anna K. Krome, Andrea Schiefer, Kenneth Pfarr, Alexandra Ehrens, Miriam Grosse, Birthe Sandargo, Ingo Stammberger, Marc Stadler,
and et al. 2024. "Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations" Pharmaceutics 16, no. 3: 386.
https://doi.org/10.3390/pharmaceutics16030386
APA Style
Becker, T., Heitkötter, J., Krome, A. K., Schiefer, A., Pfarr, K., Ehrens, A., Grosse, M., Sandargo, B., Stammberger, I., Stadler, M., Hübner, M. P., Kehraus, S., Hoerauf, A., & Wagner, K. G.
(2024). Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations. Pharmaceutics, 16(3), 386.
https://doi.org/10.3390/pharmaceutics16030386
